Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
Florida’s Commercial Clearinghouse Bill Stirring Up Concerns for Brokers, Regulators 
US Appeals Court Rejects Challenge to Trump’s Efforts to Ban DEI 
Allstate CEO Wilson Takes on Affordability Issue During Earnings Call 
Trump’s Repeal of Climate Rule Opens a ‘New Front’ for Litigation 
